TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomics
Division of General Internal Medicine
Taipei Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomicspsoriasis,
Chang Gung Medical Foundation Chang Gung Memorial Hospital, Keelung
Division of Dermatology
更新時間：2023-10-24
鐘文宏Chung, Wen-Hung
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
chung1@cgmh.org.tw
Publication
82Publications
21
62. Chung WH, Hung SI, Chen YT*. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf. 2010 Jan;9(1):15-21. (SCI; IF=2.896; Pharmacology & pharmacy: 83/255)
22
61. Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RCY, Chu CY, Chen YT*. Common risk allele in aromatic anti-epileptic-drugs induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010 Mar;11(3):349-56. (SCI; IF=2.710; Pharmacology & pharmacy: 93/255)
23
60. Chang SL, Hu S, Hung SI, Huang YL, Hsiao WC, Chung WH*. A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis. Arch Dermatol Res. 2010 Sep;302(7):525-9. (SCI; IF=2.146; Dermatology: 20/61)
24
59. Chung WH, Dao RL, Chen LK, Hung SI*. The role of genetic variants in human longevity. Ageing Res Rev. 2010 Nov;9 Suppl 1:S67-78. (SCI; IF=7.526; Cell Biology: 28/187; Geriaterics & Gerontology: 1/49)
25
58. Chung WH, Hung SI*. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010 Dec;59(4):325-32. Epub 2010 Oct 25. (SCI; IF=2.355; Allergy: 13/25; Immunology: 96/151)
26
57. Lu PH, Hui RC, Yang LC, Yang CH, Chung WH*. Prurigo pigmentosa: a clinicopathological study and analysis of associated factors. Int J Dermatol. 2011 Jan;50(1):36-43. (SCI; IF=1.415; Dermatology: 36/61)
27
56. Phillips EJ*, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA. Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol. 2011 Mar;127:S60-6. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)
28
55. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT*, Shen CY; Taiwan SJS Consortium. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011 Mar 24;364(12):1126-33. (SCI; IF=59.558; Medicine, general & internal: 1/155)
29
54. Lin JW, Shih YC, Chung WH*. Vancomycin-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol. 2011 Jul-Aug;77(4):537. (SCI; IF=1.488; Dermatology: 34/61)
30
53. Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, Hung SI*. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)
